CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of therapeutics; small molecules with the power of biologics, today announced that Ted Hibben has joined the company as Senior Vice President of Corporate Development. In this role, Ted will focus on leading Ensemble’s business development efforts and play a key part in strategic planning initiatives. Prior to joining Ensemble, Mr. Hibben held senior corporate management positions at Cequent Pharmaceuticals (now a part of Marina Biotech) and Coley Pharmaceutical Group (acquired by Pfizer).
